Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients

140Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Several studies have indicated that genetic polymorphism of apolipoprotein (apo) E is related to coronary artery disease (CAD). We therefore determined the apo E phenotype in 91 consecutive Finnish men with angiographically confirmed CAD. The apo E phenotype distribution differed significantly from that observed in the Finnish population (p < 0.05). In the patient group, the frequency of the ε4 allele was 0.324, which is 1.4-fold higher than in the normal Finnish population and twice as high as in other Caucasian populations. Serum lipoproteins and postheparin plasma lipase activities did not display any significant variation according to apo E phenotype. These studies confirm and extend, in a population with high ε4 allele frequency, the previous data on the impact of the ε4 allele on the risk of CAD and suggest that the high ε4 allele frequency in the Finnish population may be one factor contributing to Finns' increased susceptibility to CAD.

Cite

CITATION STYLE

APA

Kuusi, T., Nieminen, M. S., Ehnholm, C., Yki-Jarvinen, H., Valle, M., Nikkila, E. A., & Taskinen, M. R. (1989). Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis, 9(2), 237–241. https://doi.org/10.1161/01.atv.9.2.237

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free